Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial.

Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial.

Item
http://www.wikidata.org/entity/Q44815957
Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysisSaudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.Growth of LAPC4 prostate cancer xenograft tumor is insensitive to 5α-reductase inhibitor dutasteride.Saudi Oncology Society clinical management guidelines for prostate cancer.A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.Hormone therapy in the management of prostate cancer: evidence-based approachesIntermittent versus continuous androgen deprivation in prostate cancerKinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis.Three cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years.Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care?Relationships between times to testosterone and prostate-specific antigen rises during the first off-treatment interval of intermittent androgen deprivation are prognostic for castration resistance in men with nonmetastatic prostate cancer.Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer.International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries.Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy.Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy.
P2860

Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial.

Item
http://www.wikidata.org/entity/Q44815957
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Intermittent versus continuous ...... randomized multicenter trial.
@en
Intermittent versus continuous ...... randomized multicenter trial.
@nl
type
label
Intermittent versus continuous ...... randomized multicenter trial.
@en
Intermittent versus continuous ...... randomized multicenter trial.
@nl
prefLabel
Intermittent versus continuous ...... randomized multicenter trial.
@en
Intermittent versus continuous ...... randomized multicenter trial.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Intermittent versus continuous ...... e randomized multicenter trial
@en
P2093
P304
P31
P356
P433
P478
P577
P698